OTC · Drug Manufacturers - Specialty & Generic

INNOCAN PHARMA Corp (INNPF) Stock

$1.60 -8.05% OTC: INNPF Healthcare

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets.

Valuation

MetricValue
Price$1.60
Market Cap$7.20M
P/E Ratio-6.68
P/B Ratio1.90
P/S Ratio0.39
EPS (TTM)$-0.25
52-Week High$14.26
52-Week Low$1.60
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-31.76%
ROA-13.80%
ROCE-28.28%
Gross Margin89.81%
Operating Margin-10.00%
Net Margin-5.95%
Debt/Equity0.27
Current Ratio5.24

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$3.0M$14.0M$29.0M$27.0M
Operating Profit$-7.0M$-6.0M$4.0M$-1.0M$-1.0M
Net Profit$-10.0M$-4.0M$-5.0M$-2.0M$-1.0M
EPS$-2.91$-0.98$-1.19$-0.42$-0.25
Op Margin-3816.3%-244.9%27.9%-4.2%-4.7%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.0M$7.0M$7.0M$9.0M$11.0M
Total Liabilities$4.0M$1.0M$3.0M$2.0M$2.0M
Cash$11.0M$5.0M$4.0M$5.0M$7.0M
Borrowings$0$0$0$0$1.0M

Latest News

TSX Penny Stocks With Market Caps Under CA$300M To Consider Simply Wall St. · Jun 11, 2026 Innocan Pharma Posts Strong Q1 2026 Results*, With Revenue Surging 29.7% to US$6.47M CNW Group · May 27, 2026 Innocan Pharma LPT-CBD is featured in Pain Medicine News CNW Group · May 6, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-7.0M$-6.0M$-4.0M$-2.0M$0
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$11.0M$0$3.0M$2.0M$0
Net Cash Flow$9.0M$-6.0M$-1.0M$1.0M$2.0M
Free Cash Flow$-7.0M$-6.0M$-4.0M$-2.0M$0

Valuation & Return Ratios

MetricValue
PEG Ratio0.07
EV / EBITDA-6.83
FCF Yield-3.85%
Quick Ratio4.12
Interest Coverage-181.28
Return 1Y-74.05%
Return 3Y-75.80%
Return 5Y—

Ownership

Insiders Held20.32%
Institutions Held0.00%
Institutions Float Held0.00%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BNXT.CNBioNxt Solutions Inc. $0.30 +0.00% -4.86 $40.83M 0.00%
DOSE.CNRapid Dose Therapeutics Corp. $0.10 +0.00% -6.00 $16.22M 0.00%
GLOW.CNGlow Lifetech Corp. $0.04 +0.00% — $8.66M 0.00%
LFST.VLifeist Wellness Inc. $0.04 +0.00% -2.00 $1.70M 0.00%
PHRX.CNPharmadrug Inc. $0.01 +0.00% — — 0.00%

About INNOCAN PHARMA Corp

InnoCan Pharma Corporation is a pharmaceutical enterprise dedicated to innovating drug delivery systems by integrating cannabidiol (CBD) with diverse pharmaceutical ingredients. Its operations extend across the United States, Poland, France, and other international markets. The company actively pursues research and development into CBD-loaded exosomes for treating conditions like COVID-19, as well as advancing CBD-infused liposomes. InnoCan Pharma also commercializes a range of branded CBD-integrated pharmaceutical and topical treatment products, such as CBD eye serum, face oil, face cream, facial serum, sleeping mask, recovery lotion, and the Relief & Go spray. Established in 2018, the corporation is headquartered in Calgary, Canada.

INNOCAN PHARMA Corp is headquartered in CA.

INNOCAN PHARMA Corp (INNPF) stock trades at $1.60 with a market capitalization of $7.20M. The stock is valued at a price-to-earnings (P/E) ratio of -6.68, price-to-book of 1.90, price-to-sales of 0.39. Over the past 52 weeks the stock has ranged between $1.60 and $14.26, and currently trades 88.8% below its 52-week high.

On profitability, INNOCAN PHARMA Corp generates a return on equity (ROE) of -31.76%, return on capital employed of -28.28%, an operating margin of -10.00%, a net profit margin of -5.95%.

Official website: innocanpharma.com

Related Healthcare Stocks

LLY Eli Lilly and Company $1212.53 +3.94% JNJ Johnson & Johnson $253.04 +1.78% ABBV AbbVie Inc. $285.00 +3.88% MRK Merck & Company, Inc. Common Stock (new) $147.28 +3.73% UNH UnitedHealth Group Incorporated Common Stock (DE) $390.02 +3.25% NVS Novartis AG $145.21 +1.97% AZN AstraZeneca PLC $162.42 +4.24% TMO Thermo Fisher Scientific Inc $674.13 +1.67% AMGN Amgen Inc. $427.25 +3.49% GILD Gilead Sciences, Inc. $153.39 +3.70% ABT Abbott Laboratories $102.45 -0.16% NVO Novo Nordisk A/S $38.16 +0.25%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides